| Product Code: ETC11389138 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Japan continued to import anticoagulants primarily from Germany, Switzerland, USA, Italy, and Metropolitan France. The market remained competitive with low concentration, as indicated by the Herfindahl-Hirschman Index (HHI). However, the industry experienced a decline with a compound annual growth rate (CAGR) of -5.32% from 2020 to 2024. Furthermore, the growth rate in 2024 saw a slight improvement but remained negative at -3.46%. These trends suggest a challenging market environment for anticoagulant import shipments into Japan, highlighting the need for strategic planning and adaptation by industry players.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Anticoagulants Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Anticoagulants Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Anticoagulants Market - Industry Life Cycle |
3.4 Japan Anticoagulants Market - Porter's Five Forces |
3.5 Japan Anticoagulants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Anticoagulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Japan Anticoagulants Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Japan Anticoagulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Japan |
4.2.2 Growing aging population leading to higher demand for anticoagulants |
4.2.3 Advancements in healthcare infrastructure and technology promoting better diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Stringent government regulations and approval processes for new anticoagulant drugs |
4.3.2 High costs associated with anticoagulant medications leading to affordability issues |
4.3.3 Adverse side effects and risks associated with prolonged use of anticoagulants |
5 Japan Anticoagulants Market Trends |
6 Japan Anticoagulants Market, By Types |
6.1 Japan Anticoagulants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Anticoagulants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Japan Anticoagulants Market Revenues & Volume, By Direct Oral Anticoagulants, 2021 - 2031F |
6.1.4 Japan Anticoagulants Market Revenues & Volume, By Vitamin K Antagonists, 2021 - 2031F |
6.1.5 Japan Anticoagulants Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.2 Japan Anticoagulants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Japan Anticoagulants Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Japan Anticoagulants Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Japan Anticoagulants Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Japan Anticoagulants Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.3 Japan Anticoagulants Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.3.4 Japan Anticoagulants Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
7 Japan Anticoagulants Market Import-Export Trade Statistics |
7.1 Japan Anticoagulants Market Export to Major Countries |
7.2 Japan Anticoagulants Market Imports from Major Countries |
8 Japan Anticoagulants Market Key Performance Indicators |
8.1 Patient adherence rate to anticoagulant therapy |
8.2 Number of hospitals and clinics offering anticoagulant treatment |
8.3 Rate of adoption of novel anticoagulant therapies |
8.4 Average age of patients prescribed anticoagulants |
8.5 Number of research studies and clinical trials related to anticoagulant treatments |
9 Japan Anticoagulants Market - Opportunity Assessment |
9.1 Japan Anticoagulants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Anticoagulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Japan Anticoagulants Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Japan Anticoagulants Market - Competitive Landscape |
10.1 Japan Anticoagulants Market Revenue Share, By Companies, 2024 |
10.2 Japan Anticoagulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |